PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Return
55.85%
This Quarter Return
+6.87%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$8.03B
AUM Growth
+$755M
(+10%)
Cap. Flow
+$434M
Cap. Flow
% of AUM
5.4%
Top 10 Holdings %
Top 10 Hldgs %
21.8%
Holding
267
New
38
Increased
113
Reduced
51
Closed
27
Top Buys
| 1 |
Amgen
AMGN
|
$67.1M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$51.7M |
| 3 |
Puma Biotechnology
PBYI
|
$43.1M |
| 4 |
VR
Validus Hold Ltd
VR
|
$42.8M |
| 5 |
Dynavax Technologies
DVAX
|
$37.6M |
Top Sells
| 1 |
Medtronic
MDT
|
$55.5M |
| 2 |
Danaher
DHR
|
$45.5M |
| 3 |
Hologic
HOLX
|
$42M |
| 4 |
Becton Dickinson
BDX
|
$40.2M |
| 5 |
KITE
Kite Pharma, Inc.
KITE
|
$37.3M |
Sector Composition
| 1 | Financials | 24.29% |
| 2 | Healthcare | 23.59% |
| 3 | Technology | 21.16% |
| 4 | Communication Services | 10.1% |
| 5 | Industrials | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
TSMC
TSM
$1.22T
| $3.03M | 0.03% |
80,768
| – | – |
|
|
HMSY
202
DELISTED
HMS Holdings Corp.
HMSY
| $2.98M | 0.03% |
+150,000
| New | +$2.98M |
|
|
CALD
203
DELISTED
Callidus Software, Inc.
CALD
| $2.89M | 0.03% |
117,388
-100,069
| -46% | -$2.46M |
|
204
New Mountain Finance
NMFC
$1.13B
| $2.85M | 0.03% |
200,000
+50,000
| +33% | +$713K |
|
205
Acadia Pharmaceuticals
ACAD
$4.3B
| $2.83M | 0.03% |
75,000
-100,000
| -57% | -$3.77M |
|
206
Protagonist Therapeutics
PTGX
$3.71B
| $2.65M | 0.03% |
150,000
+50,000
| +50% | +$884K |
|
207
Aecom
ACM
$16.7B
| $2.64M | 0.03% |
71,655
-211,111
| -75% | -$7.77M |
|
|
RARX
208
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $2.56M | 0.03% |
175,000
+100,000
| +133% | +$1.46M |
|
|
MULE
209
DELISTED
MuleSoft, Inc.
MULE
| $2.52M | 0.03% |
125,100
+95,253
| +319% | +$1.92M |
|
|
MIXT
210
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $2.44M | 0.03% |
245,454
| – | – |
|
211
Exelixis
EXEL
$10.1B
| $2.42M | 0.03% |
100,000
-90,000
| -47% | -$2.18M |
|
212
Moody's
MCO
$89.6B
| $2.4M | 0.03% |
17,212
| – | – |
|
213
HDFC Bank
HDB
$181B
| $2.27M | 0.03% |
47,136
-11,670
| -20% | -$562K |
|
|
MTLS
214
Materialise
MTLS
$294M
| $2.04M | 0.02% |
141,662
| – | – |
|
|
BSFT
215
DELISTED
BroadSoft, Inc.
BSFT
| $1.88M | 0.02% |
37,396
| – | – |
|
|
TWTR
216
DELISTED
Twitter, Inc.
TWTR
| $1.79M | 0.02% |
106,125
| – | – |
|
217
AnaptysBio
ANAB
$590M
| $1.75M | 0.02% |
50,000
+20,000
| +67% | +$699K |
|
218
SoundThinking
SSTI
$149M
| $1.31M | 0.01% |
+97,868
| New | +$1.31M |
|
|
WWE
219
DELISTED
World Wrestling Entertainment
WWE
| $1.31M | 0.01% |
+55,580
| New | +$1.31M |
|
220
Summit Therapeutics
SMMT
$17.7B
| $1.25M | 0.01% |
+100,000
| New | +$1.25M |
|
|
VRNA
221
Verona Pharma
VRNA
$9.19B
| $1.17M | 0.01% |
+75,917
| New | +$1.17M |
|
222
Citizens Financial Group
CFG
$22.7B
| $1.14M | 0.01% |
30,056
+1,820
| +6% | +$68.9K |
|
223
argenx
ARGX
$44.9B
| $1.12M | 0.01% |
+50,000
| New | +$1.12M |
|
|
ADAP
224
Adaptimmune Therapeutics
ADAP
$13.5M
| $819K | 0.01% |
+100,000
| New | +$819K |
|
|
ESV
225
DELISTED
Ensco Rowan plc
ESV
| $635K | 0.01% |
26,610
| – | – |
|